Parametric Mean Survival Time Analysis in Gastric Cancer Patients

Medical Decision Making

Volumn 24, Issue 2, 2004, Pages 131-141

  Maetani, Shunzo ^a   Nakojima, Toshifusa ^b   Nishikawa, Toshikuni ^c  

^a Tenri Institute of Medical Research   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c TENRI HOSPITAL   (Japan)

Author keywords

Boag model; Cohort life table; Disease related survival curve; Mean survival time; Outcome indicator; Parametric survival model

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MEDICAL TECHNOLOGY; PARAMETRIC TEST; PATIENT CARE; PREDICTION; STATISTICAL ANALYSIS; STATISTICAL MODEL; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK; STOMACH NEOPLASMS; SURVIVAL RATE; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 1642281543     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X04263253     Document Type: Article

References (33)

1. Wright JC, Weinstein MC. Gains in life expectancy from medical interventions: standardizing data on outcomes. N Engl J Med. 1998;339:280-6.
2. Tan LB, Murphy R. Shifts in mortality curves: saving or extending lives? Lancet. 1999;554:1378-81.
3. Messori A, BecagliP, Tripoli S. Median versus mean lifetime survival in the analysis of survival data. Oncol Report. 1999;6:1135-41.
4. Beard SM, Holmes M, Price C, et al. Hepatic resection for colorectal liver metastases: a cost-effective analysis. Ann Surg. 2000;232:763-76.
5. Maetani S, Yamazoe Y, Onodera H, Imamura M. Estimation of mean survival time from limited follow-up in cancer patients. Tenri Medical Bulletin. 1998;1:38-49.
6. Maetani S, Matsusue S. Mean survival time in gastric cancer patients estimated from a parametric model: comparison with long-term follow-up results. Tenri Medical Bulletin. 2000;3:15-25.
7. Boag JW. Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J Roy Statist Soc. 1949;B11:15-53.
8. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 13th ed. Tokyo: Kanehara; 1999.
9. International Union against Cancer. TNM Classification of Malignant Tumors. 5th ed. New York: John Wiley & Sons; 1997.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-81.
11. Irwin JO. The standard error of an estimate of expectation of life, with special reference to expectation of tumourless life in experiments with mice. J Hygiene. 1949;47:188-9.
12. Kobayashi K, Nanjo Z. Generation Life Tables for Japan Based on Period Life Tables Covering the Years 1890-1986. Tokyo: Nihon University Population Research Institute; 1988.
13. Statistics and Information Department of the Minister's Secretariat. The 18th Life Tables. Tokyo: Health and Welfare Statistics Association; 1997:1-240, 1998:1-336.
14. Statistics and Information Department of the Minister's Secretariat. The Abridged Life Tables 1999. Tokyo: Japanese Ministry of Health and Welfare; 2000.
15. Gross AJ, Clark VA. Survival Distributions: Reliability Applications in the Biomedical Sciences. New York: John Wiley & Sons; 1975.
16. Maetani S, Tobe T, Hirakawa A, Kashiwara S, Kuramoto S. Parametric survival analysis of gastric cancer patients. Cancer. 1980;46:2709-16.
17. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician. 1983;22:307-17.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-10.
19. Altman GA, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. BMJ. 1983;286:1489-93.
20. Murray GD. The task of a statistical referee. Br J Surg. 1988;75:664-7.
21. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measure of the consequences of treatment. N Engl J Med. 1988;318:1728-33.
22. Lubsen J, Hoes A, Grobbee D. Implications of trial results: the potentially misleading notions of number needed to treat and average duration of life gained. Lancet. 2000;356:1757-9.
23. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med. 1966;105:429-35.
24. Lau EW. Visual illusions created by survival curves and the need to avoid potential misinterpretation. Med Decis Making. 2002;22:238-44.
25. Berg JW. The distribution of cancer patients in time: survey test of the lognormal model. Br J Cancer. 1965;19:695-711.
26. Rutqvist LE, Wallgren A, Nilsson B. Is breast cancer a curable disease? Cancer. 1984;53:1793-800.
27. Mould RF, Boag JW. A test of several parametrical statistical models for estimating success rate in the treatment of carcinoma cervix uteri. Br J Cancer. 1975;32:529-50.
28. Mould RF, Hearnden T, Palmer M, et al. Distribution of survival times of 12,000 head and neck cancer patients who died with their disease. Br J Cancer. 1976;34:180-90.
29. Tivey H. The prognosis for survival in chronic granulocytic and lymphocytic leukemia. Am J Roentgenol. 1954;72:68-93.
30. Hanson TAS, Histological classification and survival in Hodgkin's disease: a study of 251 cases with special reference to nodular sclerosing Hodgkin's disease. Cancer. 1964;171:1595-603.
31. Dehnam JW, Dehnam E, Dear KB, et al. The follicular non-Hodgkin's lymphomas: I. The possibility of cure. Eur J Cancer. 1996;32A: 470-9.
32. Gamel JW, McLean IW, Rosenberg SH. Proportion cured and mean log survival time as functions of tumor size. Stat Med. 1990;9:999-1006.
33. Sakamoto Y. Efficient use of Akaike's information criterion for model selection in high dimensional analysis. Metron 1982;40:257-75.